Pure Global
Disease/Condition
2,416 Clinical Trials
10+ Countries

Hypertension Clinical Trials Database - Free Access to 2,416 Studies

Access comprehensive clinical trial information for Hypertension through Pure Global AI's free database. This collection includes 2,416 clinical trials across multiple phases including N/A, Phase 4, Phase 3. Currently, 258 trials are actively recruiting participants.

Research for Hypertension is being conducted in United States of America, Japan, China and 7+ other countries. Leading sponsors include Boehringer Ingelheim and Novartis. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Free Database
Powered by Pure Global AI
840K+ Global Trials
Updated Daily
By Phase
N/A
1,248
Phase 4
360
Phase 3
299
Phase 1
165
Not Applicable
162
By Status
Completed
1,445
Unknown
261
Recruiting
258
Not yet recruit...
214
Terminated
95
Top Countries
United States of America528
Japan248
China243
South Korea122
Brazil96
Top Sponsors
Boehringer Ingelhe...107
Novartis102
Novartis Pharmaceu...32
Chong Kun Dang Pha...31
Novartis Pharma Se...30
Recent Trials
Latest clinical trials for Hypertension
2011-004411-22

An extension study to evaluate long term growth and development of hypertensive children 6-17 years of age previously treated with a substance called aliskiren

Novartis Pharma Services AG
2012-000855-15

Study to determine bioavailablity of 300 mg aliskiren mini-tablets vs 300 mg aliskiren market tablet.

Novartis Pharma Services AG
2016-004323-23

Clinical trial in Healthy Volunteers to test Valsartan Pharmacokinetics

Novartis
2015-003328-30

Olmesartan Pediatric Pharmacokinetic (PK) Study

Daiichi Sankyo Pharma Developm...
2015-003329-32

Assessment of Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescent Patients With High Blood Pressure

Daiichi Sankyo Pharma Developm...
SLCTR_2023_009
Phase 3
Recruiting

Efficacy and safety of GMRx2 (a single pill combination containing telmisartan/amlodipine/indapamide) compared to placebo for the treatment of hypertension: An international, multi-center, randomized, double-blind, placebo-controlled, parallel-group trial

George Medicines Pty LimitedAustralia;Nigeria;Sri Lanka;United Kingdom;United States of America
SLCTR_2016_005
Not Applicable
Completed

Control of Blood Pressure and Risk Attenuation- Bangladesh, Pakistan & Sri Lanka

Professor Tazeen JafarBangladesh, Pakistan, Sri Lanka
SLCTR_2015_020
Not Applicable

TRIUMPH - TRIple Pill vs. Usual care Management for Patients with mild - to - moderate Hypertension

The George Institute for Globa...Sri Lanka
SLCTR_2017_029
Not Applicable
Withdrawn

Acupuncture therapy in reducing high blood pressure

Ministry of Health, Government...Nepal
SLCTR_2018_032
Not Applicable

A randomized controlled trial comparing the efficacy of pregabalin versus lignocaine for attenuating the intubation response in hypertensive patients.

Vinayaka Missions Medical Coll...India
SLCTR_2021_007
Phase 3
Recruiting

Efficacy and safety of GMRx2 (a single pill combination containing telmisartan/amlodipine/indapamide) compared to dual combinations for the treatment of hypertension: An international, multi-center, randomized, double-blind, active-controlled, parallel-group trial.

Dr. Karl RobertsSri Lanka
NCT06415071
Completed

Hypertension Longitudinal Data Platform in Tianjin

West China HospitalChina
NCT06401759
Recruiting

Use of Podcasts in the Education of Hypertension Patients

Firat UniversityTurkey
NCT06391073
Not yet recr...

Reach Out 2: Emergency Department-Initiated Hypertension Mobile Health Intervention Connecting Multiple Health Systems

Northwestern UniversityUnited States of America
NCT06359691
Not yet recr...

Multi-ethnic Multi-level Strategies and Behavioral Economics to Eliminate Hypertension Disparities in Los Angeles County

University of California, Los ...United States of America
NCT06368206
Not yet recr...

Evaluation of the Performance and Safety of the Aktiia Spot-check Optical Blood Pressure Monitoring (OBPM) Device at Fingertip (Aktiia G2C) Against Double Auscultation, and Comparison With Oscillometry and Aktiia Bracelet G2

Aktiia SASwitzerland
NCT06354192
Not yet recr...

Precision Nudging for Hypertension Management: Observational Study

Lirio
NCT06358378
Not yet recr...

Accuracy of Cuffless Ambulatory Blood Pressure Monitors Compared to Cuff-based Monitors in an Ambulatory Elderly Population: A Pilot Study

Sligo General Hospital
NCT06346886
Not yet recr...

HTN App for HTN Control and Cardiovascular Health Among African-Americans

Mayo ClinicUnited States of America
NCT06380712
Not yet recr...

HYPERTESSA HyperTessa User Experience Study (HTUX)

Fondazione Policlinico Univers...Italy
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
About Hypertension Research

Pure Global AI provides free access to 2,416 clinical trials studying Hypertension, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Boehringer Ingelheim, Novartis, Novartis Pharmaceuticals, among others.

Quick Facts
Total Trials2,416
Countries10+
Sponsors10+
Recruiting258